Announcements and Notices - [Other - Business Update]

Transcenta Holding Limited operates as a global biotherapeutics company. The Company develops therapeutic antibody molecules for oncology and selected non-oncology indications including bone and kidney disorders. Transcenta Holding provides services in China.

Voluntary Announcement-Business Update On Promising Anti-Tumor Activity Of Novel Liv-1 Targeting Adcs With Site-Specific Conjugated Topo I Inhibitor Payload In Tnbc Tumor Models At 2024 Sabcs

Next Day Disclosure Returns - [Share Buyback]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00